AI-driven virtual disease models for drug discovery and clinical prediction
Turbine builds computational disease models that simulate biological responses to drugs, helping pharma research teams run virtual experiments instead of physical lab work. The tech stack—Databricks, Snowflake, Python, TensorFlow, PyTorch—reflects a machine-learning-first approach to biology. Current hiring emphasis on research and engineering roles, paired with active projects in simulated cell models and cancer modeling platforms, signals focus on deepening the fidelity of their virtual experiments rather than scaling sales.
Notable leadership hires: Head of People
Turbine virtualizes biological experiments using AI to compress drug discovery timelines and reduce clinical failure rates. The platform generates computational disease models that predict how cells and tissues respond to treatment, allowing researchers to run billions of simulations before committing to physical experiments. Founded in 2016 and headquartered in Budapest, Turbine operates as a 51–200 person organization with validated partnerships in pharma. The company is actively scaling research and engineering capacity across Hungary and the United States, while investing in laboratory automation protocols and organizational infrastructure to support rapid growth.
Turbine's stack centers on Databricks, Snowflake, Python, TensorFlow, and PyTorch. The company also uses Apache Spark and JAX for computational work, with Azure as its cloud platform and Snowflake for data warehousing.
Active projects include simulated cell models, cancer cell modeling platforms, high-throughput screening protocols, laboratory automation, data pipeline development for quality control, and contract lifecycle management system implementation.
Other companies in the same industry, closest in size